Goodpasture Syndrome and D-Penicillamine

Abstract

Comments and Correction1 January 1976Goodpasture Syndrome and D-PenicillamineTERRY GIBSON, M.B., HUGH C. BURRY, M.B., F.R.C.P., CHISHOLM OGG, M.D., F.R.C.P.TERRY GIBSON, M.B.Search for more papers by this author, HUGH C. BURRY, M.B., F.R.C.P.Search for more papers by this author, CHISHOLM OGG, M.D., F.R.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-84-1-100_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: It has recently been suggested in this journal that the Goodpasture syndrome may be caused by D-penicillamine treatment (1). We wish to report another case in which the clinical picture of this syndrome occurred during treatment with this drug.A 51-year-old white man with a 6-year history of sero-positive, erosive, and nodular rheumatoid arthritis began treatment with D-penicillamine in August 1972. His illness had been complicated by a pleural effusion in May 1972, but there had been no other systemic features. D-Penicillamine was prescribed in slowly increasing daily doses to a maximum of 1.2 g per day....References1. STERNLIEBBENNETTSCHEINBERG IBI: D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 82:673-676, 1975 LinkGoogle Scholar2. POSKITT T: Immunologic and electron microscopic studies in Goodpasture's syndrome. Am J Med 49:250-257, 1970 CrossrefMedlineGoogle Scholar3. RUSBYWILSON NC: Lung purpura with nephritis. Q J Med 29:501-511, 1960 MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Guy's Arthritis Research Unit and Department of Renal Medicine Guy's Hospital London SE1 9RT United Kingdom PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByA Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal SyndromeUrinary TractGold salts, D-penicillamine and allopurinold-Penicillamine–Induced ANCA-Associated Crescentic Glomerulonephritis in Wilson DiseaseUrinary TractLung Injury Caused by Pharmacologic AgentsGold salts, D-penicillamine and allopurinolCutaneous and Systemic Manifestations of Drug-Induced VasculitisRapidly Progressive Glomerulonephritis with d-PenicillamineUrinary TractPULMONARY TOXICITY OF DRUGS USED TO TREAT SYSTEMIC AUTOIMMUNE DISEASESAlveolar HemorrhageNephrotoxicity of gold salts, D-penicillamine, and allopurinolCategory III Symptom-Modifying Antirheumatic DrugsEtiology and management of cystine lithiasisAntirheumatic drug reactions in the lungRheumatic syndromes caused by antirheumatic drugsPrediction of organ system toxicity with antirheumatic drug therapyRenal disorders in rheumatoid arthritisPulmonary complications of antirheumatic drug therapyPulmonary Disease Due to Antirheumatic AgentsKinetics of immune deposits in membranous nephropathyThe Natural Course of Gold and Penicillamine Nephropathy: A Longterm Study of 54 PatientsMANAGEMENT OF RHEUMATOID ARTHRITISNatural course of penicillamine nephropathy: a long term study of 33 patientsPenicillamine-Induced Rapidly Progressive Glomerulonephritis in Patients With Progressive Systemic Sclerosis: Successful Treatment of Two Patients and a Review of the Literatured-penicillamine: Chemistry and clinical use in rheumatic diseasePenicillamine-induced proteinuria: Risk factorsGLOMERULONEPHRITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): Report of Five Cases and Review of the LiteratureSlow-acting antirheumatoid drugsRapidly progressive glomerulonephritis with glomerular crescent formation in rheumatoid arthritisSyndrome de Goodpasture au cours d'une polyarthrite rhumatoïde traitée par la D. PénicillamineD-Penicillamine-induced pemphigus syndromeMICROSCOPIC HAEMATURIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON d-PENICILLAMINEPulmonary haemosiderosis and pulmonary haemorrhageInduction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseasesRelationship of gold and penicillamine therapy to diffuse interstitial lung disease.Penicillamine nephropathy.d-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis—Successful treatment with plasmapheresis and immunosuppressivesToxische Nierensch�denAdverse Effects of D-Penicillamine in Rheumatoid ArthritisHOWARD B. STEIN, M.D., A. CAROLINE PATTERSON, M.B., ROBERT C. OFFER, M.D., CHRISTOPHER J. ATKINS, M.B., ALVENA TEUFEL, R.N., HAROLD S. ROBINSON, M.D.Medikamentöse Schäden der NiereDrug-Associated NephropathyPenicillaminePart II: D-PenicillaminePenicillamine in Rheumatoid Arthritis: Adverse EffectsPulmonary and pleural lesions in rheumatoid diseaseTreatment of rheumatoid arthritis with penicillamineHeavy metal antagonists 1 January 1976Volume 84, Issue 1Page: 100-100KeywordsDrugsPleural effusionRheumatoid arthritis Issue Published: 1 January 1976 PDF DownloadLoading ...